KPF
ZBH icon

K2 Principal Fund’s Zimmer Biomet ZBH Stock Holding History

K2 Principal Fund’s Portfolio ZBH Stock Details ZBH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q4 		– Sell
-11,536
Closed -$1.51M – 429
2021
Q3 		$1.64M Buy
11,536
+5,768
+100% +$848K 0.13% 150
2021
Q2 		$901K Buy
5,768
+2,884
+100% +$467K 0.07% 237
2021
Q1 		$448K Sell
2,884
-2,781
-49% -$431K 0.04% 257
2020
Q4 		$847K Hold
5,665
– – 0.07% 214
2020
Q3 		$749K Buy
+5,665
New +$740K 0.11% 174

Other funds holding ZBH

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
American Century Companies
American Century Companies Kansas City, Missouri $194B AUM 35% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

K2 Principal Fund's ZBH Position: Q4 2021 in Review

K2 Principal Fund sold out of Zimmer Biomet (ZBH) in Q4 2021, closing a stake of 11,536 shares — an estimated $1.51M sold.

K2 Principal Fund first reported a position in ZBH in Q3 2020 and held it in 5 quarters. The position peaked at $1.64M in Q3 2021. 998 funds tracked by Wall St. Rank hold ZBH as of Q4 2021.

  • K2 Principal Fund reported no remaining Zimmer Biomet position as of Q4 2021 after selling out during the quarter.
  • K2 Principal Fund sold 11,536 Zimmer Biomet shares in Q4 2021, an estimated $1.51M.
  • K2 Principal Fund first reported a position in Zimmer Biomet in Q3 2020 and held it in 5 quarters.
  • K2 Principal Fund's Zimmer Biomet position peaked at $1.64M in Q3 2021.
  • 998 funds tracked by Wall St. Rank held Zimmer Biomet as of Q4 2021.

Based on K2 Principal Fund's 13F filing for Q4 2021, filed 11 Feb 2022.